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Abstract.  C3bi receptors (CR3) on human polymor- 
phonuclear leukocytes (PMN) bind ligand-coated parti- 
cles and promote their ingestion. The binding activity 
of CR3 is not constitutive but is transiently enabled by 
phorbol esters (Wright, S. D., and B.  D. Meyer, 1986, 
J.  Immunol.  136:1759-1764). Our observations indicate 
that the capacity of CR3 to bind ligand is tightly cor- 
related with the degree of ligand-independent aggrega- 
tion of the receptor in the plane of the membrane. 
Fixed PMN were labeled with anti-CR3 monoclonal 
antibodies and streptavidin colloidal gold before view- 
ing in the electron microscope either en face or in thin 
section. On unstimulated PMN, gold particles marking 
CR3 were dispersed randomly. Stimulation of PMN 
for 25 min with phorbol myristate acetate (PMA) dra- 
matically enhances binding of C3bi-coated particles, 
and the CR3 on such stimulated cells was observed in 
clusters containing more than six gold particles. CR3 
was not aggregated over coated pits. After 50 min in 
PMA, the binding activity of CR3 falls, and the distri- 
bution of CR3 was again observed to be disperse. If a 
hydrophilic phorbol ester was washed away after a 20- 
min stimulation, binding activity remains elevated for 
at least 50 min, and CR3 remained aggregated. Thus, 
clustering of CR3 was temporally correlated with its 
ability to bind ligand and initiate phagocytosis. Unlike 
CR3, Fc receptors and HLA did not exhibit changes in 
their aggregation state in response to PMA. Treating 
PMN with formyl-methionyl-leucyl-phenylalanine, 
which enhances expression of CR3 but not its func- 
tion, did not lead to aggregation of CR3.  These obser- 
vations suggest that a clustered configuration is a pre- 
condition necessary for binding ligand and signaling 
phagocytosis. 
T 
RANSFER of information occurs bi-directionally across 
the plasma membrane. Ligation of receptors on the 
cell surface can influence a  variety  of intracellular 
processes, such as DNA synthesis, glucose metabolism, and 
reorganization  of the cytoskeleton.  Physiological  changes 
within the cell may also alter the binding properties of recep- 
tors. For example, treatment of cells with phorbol esters has 
been reported to  regulate  the avidity  of receptors for C3 
(Wright  and Meyer,  1986), the insulin  receptor (Thomo- 
poulos  et al.,  1982; Grunberger and Gordon,  1982), the 
epidermal growth  factor receptor (King and Cuatrecasas, 
1982), and tx- and 13-adrenergic  receptors (Leeb-Lundberg et 
al..  1985; Kelleher et al..  1984). 
The mechanisms by which receptors transmit signals into 
the cell are not fully understood, but, in several instances, 
ligands that initiate signals are also observed to cause aggre- 
gation  of their  receptors  (King  and  Cuatrecasas,  1981). 
Moreover, signaling can be initiated by aggregating receptors 
for epidermal growth factor, IgE, or insulin with anti-recep- 
tor antibodies  (Schreiber et al.,  1983; Isersky et al.,  1978; 
Jacobs  et al.,  1978). Monomeric IgE (Segal et al.,  1977), 
CNBr fragments of epidermal growth factor (Schechter et 
al.,  1979), and D-pyroGlu-D-Phe-D-Trp-D-Lys-GnRH,  an 
antagonist of gonadotropin-releasing  hormone (Conn et al., 
1982), each bind to their respective receptors but fail to in- 
duce signaling.  Cross-linking  these ligands,  however, en- 
ables them to initiate intracellular signals. Thus the view has 
emerged that receptor aggregation is necessary and sufficient 
for the transmission  of signals  to the cytoplasm  (Kagey- 
Sobotka et al., 1982; Schlessinger, 1986; Kahn et al., 1978; 
Conn et al., 1985). We have investigated the reciprocal possi- 
bility that alterations  within the cell may affect the activity 
of receptors for complement on the cell surface by changing 
their state of aggregation. 
The C3bi receptor (CR3) ~  on human polymorphonuclear 
leukocytes (PMN) recognizes C3bi,  a cleavage product of 
C3, bound to the surfaces of particles and initiates phagocy- 
tosis of the opsonized  particles.  CR3  is composed of two 
polypeptide chains, an a of 185 kD and a 13 of 95 kD as an 
a1131 dimer (Wright  et al.,  1983; Sanchez-Madrid  et al., 
1983). Recent work indicates that CR3 recognizes a region 
of C3bi that contains the triplet,  Arg-Gly-Asp (RGD), and 
exhibits both structural  and functional  homology with the 
fibronectin receptor and related adhesion-promoting  recep- 
1. Abbreviations used in this paper:  CR3, C3bi  receptors;  EC3bi,  C3bi- 
coated erythrocytes; FMLP, formyl-methionyl-leucyl-phenylalanine; HLA, 
human leukocyte antigen; HSA, human serum albumin;  NBCS, newborn 
calf serum;  PD,  PBS without CaCI2 or MgCI2; PMA, phorbol  myristate 
acetate;  PMN,  polymorphonuclear  leukocytes. 
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1987; Kishimoto et al.,  1987). 
The function of CR3 on monocytes and PMN can be regu- 
lated by several different stimuli (Wright and Griffin, 1985). 
For example,  on PMN the activity of CR3 is enhanced by 
phorbol esters (Wright and Meyer, 1986). Resting cells ex- 
press  receptors on their cell surface that bind C3bi-coated 
erythrocytes (EC3bi) very poorly. Treatment of PMN with 
phorbol myristate acetate (PMA) increases binding of EC3bi 
sixfold, but the effect of PMA  is transient, and binding of 
EC3bi falls to control levels after 50-rain treatment with the 
phorbol ester. Phagocytosis  of EC3bi  is also regulated by 
PMA  and  exhibits  an  enhancement  and  depression  con- 
gruent with binding.  The rise  and decline  in binding  and 
phagocytosis cannot be explained on the basis of changes in 
the expression of CR3 on the cell surface, since the number 
of receptors increases only twofold after 15 min in PMA and 
does  not  decline with longer  incubation  times.  Thus  the 
mechanism by which PMA alters the binding and signaling 
capacity of CR3 appears to involve primarily changes in the 
nature of the receptor, not in the number of receptors. 
We have used a direct method,  immunoelectron micros- 
copy, to determine the distribution of CR3 before and during 
PMA treatment. Our observations suggest that enhanced ac- 
tivity  of CR3  is  closely  correlated with the  clustering  of 
receptors in the plane of the membrane. Disaggregation of 
the receptors correlates with loss of receptor activity. 
Materials and Methods 
Preparation of  PMN Leukocytes 
Fresh blood was collected from healthy human donors, and PMN were iso- 
lated on Ficoll-Hypaque  gradients (English and Anderson, 1974). 
Reagents and Buffers 
PMA, phorbol dibutyrate,  fvrmyl-methionyl-leucyl-phenylalanine (FMLP), 
Aprotinin, and ethyldimethylaminopropyl  carbodiimide were supplied  by 
Sigma Chemical Co., St. Louis, MO. Human serum albumin (HSA) was 
supplied by Worthington Bioehemieals,  Malvern, PA. Newborn calf serum 
(NBCS) was purchased from Gibco, Grand Island, NY. Glutaraldehyde and 
OsO4 were purchased from Electron Microscopy  Sciences,  Fort Washing- 
ton, PA. Buffers used were:  PBS (137 mM NaCI,  2.7 mM KCI, 0.9 mM 
CaCI~, 0.5 mM MgC12 and 8 mM phosphate, pI-I 7.4) (Dulbecco and Vogt, 
1954); PBS without CaC12 or MgCI2 (PD); and PBS, 0.05%  glucose,  0.5 
mg/ml HSA,  and 1:50 Aprotinln (HAP). 
Antibodies 
Monoclonal antibodies OKM1 and OKMI0, directed against the a chain of 
CR3 (Wright et al.,  1983), 3G8 directed against the Fc receptor (FcRrmo) 
(Fleit et al.,  1982), and W6/32 directed against human leukocyte antigen 
(HLA) (Barnstable et al.,  1978) were used in this study. Antibodies were 
purified  on protein A-Sepharose  columns and were biotinylated by stan- 
dard procedures (Berman and Basch, 1980). Affinity-purified F(ab)'2 anti- 
mouse immunoglobulin was supplied by Boehringer Mannheim Biochemi- 
cals, Indianapolis,  IN, and was iodinated by the Iodogen procedure (Fraker 
and Speck,  1978) to specific activities of 106-107 cpm/l.tg. 
Streptavidin-Colloidal Gold 
For the initial phases of this study, streptavidin-conjugated  colloidal gold 
was kindly provided by Dr. Frank Konings of Janssen Life Sciences  Prod- 
ucts. In addition, 6- and 10-ran colloidal gold was prepared by the method 
of Slot and Geuze (1985), and streptavidin was conjugated to it by standard 
procedures (DeMey,  1984). Each preparation of colloidal gold was charac- 
terized by electron microscopy to determine  the size distribution  of  the patti- 
cles and the degree of aggregate formation. Only those preparations with 
uniform size and having >99% of gold particles present as individuals were 
used for labeling experiments. 
Binding of  Antibody to Fixed Cells 
To test for the ability of different fixation protocols to presexve antigenicity, 
we used a radioactive antibody-binding assay. PMN were plated in 60-well 
Terasaki plates and subjected to different test fixatives, including (a) dilute 
glutaraldehyde  (0.05-0.3%) in PBS,  10 rain at room temperature,  (b) 1% 
ethyldimethylaminopropyl  carbodiimide plus dilute glutaraldehyde  (0.05- 
0.3%) in PBS/phospbate/Tris,  pH 7.0 at room temperature for 7 rain (W'fl- 
lingham, 1980), and (c) 20 mM ethylacetimidate,  3% paraformaldehyde, 
2-10 rain at room temperature,  followed by 3% paraformaldehyde,  0.1% 
glutaraldehyde,  1 h on ice (Geigar et al.,  1981). After two 15-min incuba- 
tions in ice-cold 0.5 mg/ml NaBI-14 in PBS and 15 rain in PD,  1% NBCS, 
the survival of antigens was measured as previously  described (Wright and 
Meyer,  1986). Briefly, the fixed cells were exposed to monoelunal antibod- 
ies for 1 h, washed,  exposed  to L~I-F(ab)'2 anti-mouse IgG for 1 h, and 
washed again.  After careful aspiration of the remaining wash solution, the 
individual wells were cut apart and counted in a gamma counter.  Unfixed 
cells exposed to the same antibodies served as controls. We found that fixa- 
tion in  1%  ethyldimethylaminopropyl  carbodiimide/0.2%  glutaraldehyde 
(W~fllingham, 1980) was the most effective in preserving the anti~enlcity of 
a variety of epitopes:  >90% of antibody binding was retained after fixation 
for the antibodies used in this study. 
We used a similar assay to determine the expression of antigens on the 
surfaces of unfixed PMN after the cells had been stimulated  with 30 ng/ml 
PMA for different lengths of time. 
Immunoelectron Microscopy 
A modification of the method of Hopkins (1985) was used to prepare whole- 
mounts of cells for irnmunoelectron microscopy.  Glass coverslips  were 
precoated with HSA by incubating them with buffer containing the protein 
(HAP) at room temperature for 20 rain. HAP was removed by washing in 
PBS with 0.05% glucose,  and PMN at 2  x  10  ~ cells/rnl were plated on the 
precoated coverslips.  After exposure to the experimental conditions de- 
scribed in Results, the cells were fixed in 1% ethyldimethylaminopropyl  car- 
bodiimide/0.2% glutaraldehyde  (W'fllingham,  1980), incubated 15 min in 
ice-cold 0.5 mg/ml NaBH4 in PBS, and then in PD,  1% NBCS for 15 rain. 
Cells were exposed to saturating concentrations of biolinylated monoclonal 
antibodies for 1 h on ice, washed in PD-NBCS,  exposed to 10~nm strep- 
tavidin-conjugated  colloidal gold, diluted to an ODs20 of 0.3-0.5,  for 2 h on 
ice and washed again in PD,  1% NBCS.  Samples were then fixed at room 
temperature for 45 rain in 2.5%  glutaraldehyde  in 0.1  M Na cacodyla~ 
buffer,  pH 7.4,  and postfixed  on ice for 15 rain in 1% OsO4 in the same 
buffer. After dehydration in ethanol, the samples were critical-point-dried 
and rot~y shadowed with Pt-C in either a freeze-fracture  apparatus (Bal- 
zers) or a vacuum evaporator  (Edwards High Vacuum, Inc., Grand Island, 
NY).  Replicas  were removed with dilute bydrofluoric  acid and picked up 
on formvar- and carbon-coated grids.  Samples were viewed on a JEOL 100 
CX microscope at 80 IN,  and the peripheral areas of cells were photo- 
graphed. The label observed on the cell periphery was found to be represen- 
tative of labeling over the entire cell surface,  as no differences  in labeling 
were observed between peripheral and perinuclear regions of membrane on 
thin-sectioned samples  (data not shown). 
For thin-sectioned samples,  PMN at 2  ￿  106 cells/ml were plated in 
plastic dishes precoated with HSA and fixed and labeled as for the prepara- 
tion of replicas, with the exception that 6-nm streptavidin-conjugated  colloi- 
dal gold was used for labeling.  The cells were  then fixed on ice in two 
changes of 0.8%  ghtaraldehyde/0.6% OsO4 in 0.1  M Na cacodylate,  pH 
7.4,  for 30 rain and postfixed  in 1% OsO4 in the same buffer for 15 rain 
(Hirsch and Fedorko,  1968). After dehydration in ethanol, monolayers were 
released from the plastic surface by adding propylene oxide (Steinman and 
Cohn, 1972), collected in microfuge tubes, pelleted, and embedded in Epon 
for thin-sectioning.  Sections were stained in uranyl acetate and lead citrate 
before  viewing. 
The specificity  of labeling was  determined in control experiments in 
which the binding of biotinylated antibody was inhibited  by a 70-fold excess 
of unbiotinylated antibody.  Binding of streptavidin-colloidal gold to PMN 
under these conditions was undetectable (data not shown). Binding of strep- 
tavidin gold to PMN was  less than four particles per cell when the bi- 
otinylated  antibody was  omitted  from  the  labeling protocol  for  whole 
mounts. 
The Journal of Cell Biology, Volume 105, 1987  1138 Figure 1.  Immunolocalization of CR3 during treatment of PMN with PMA.  PMN were incubated at 37~  for a total of 50 min, and at 
intervals 30 ng/ml PMA was added to the cells. Samples were then fixed and labeled as whole mounts with OKM10 and streptavidin gold 
as described in Materials and Methods. The length of exposure of cells to PMA was (a) 0  min (no PMA),  (b)  10 min, (c) 25 min, and 
(d) 50 min. Bar, 0.2 Itm. 
Quantitation 
The size of receptor clusters was determip,  ed by counting  the number  of  gold 
particles associated in each distinguishable cluster on whole mount sam- 
pies. To warrent inclusion in the same cluster, gold particles were no more 
than 30-m apart. For each experimental condition an average of 4,000 gold 
particles was counted by an individual unaware of the experimental  condi- 
tion, and the percentage of total gold particles in each size of cluster was 
determined and graphed as a histogram. The data presented in this report 
are representative of at least three labeling experiments for each experimen- 
tal condition. 
Although the stoichiometry of binding of gold particles to receptors can- 
not be determined precisely, it is unlikely that individual receptors were la- 
beled by more than one gold particle.  Our experiments used monoclonal an- 
tibodies,  so no more than one antibody should be bound per receptor.  Each 
antibody molecule was biotinylated on at least one site,  since the strep- 
tavidin gold adsorbed >90% of biotinylated OKM10 in control experiments 
(data not shown).  The observation that labeling of CR3 on resting cells 
(e.g., Fig.  1 a) yielded single gold particles confirmed the assumption that 
antibodies bound no more than one gold particle. Thus the number of gold 
particles per cluster is proportional to the number of receptors per cluster, 
and clusters containing n gold particles contain at least n receptors. 
The density of labeling was determined by counting the number of parti- 
cles in each square (0.5 p.m  2) of a grid laid over images of whole mount 
samples. At least seven areas from each of 30 cells were counted for each 
experimental condition. The density of labeling varied in different experi- 
ments and varied from cell to cell within an experiment. Thus, data from 
three separate experiments were averaged and the standard deviation deter- 
mined. 
Assays for  Attachment and Phagocytosis  of 
Ligand-coated Erythrocytes 
Sheep etTthrocy~ (E) were coated with ,u20,000 IgG/E or ,~80,000 C3bi/E 
as previously described (Wright and Silverstein,  1982). The binding of these 
erythrocytes  to monolayers  of PMN was measured by adding 50 erythro- 
cytes per PMN and incubating the preparation at 37"C for 30 rain. Unbound 
erythrocytes  were then washed  away, and binding was  scored by phase- 
contrast microscopy.  The number of attached erythrocytes per 100 phago- 
cytes is termed the Attachment Index (AI). Measurement of the Phagocytic 
Index (PI) was made in a similar fashion and was scored after lysing bound 
but uningested E by a brief exposure to distilled water (Wright and Silver- 
stein, 1982). Control experiments indicated that uncoated erythrocytes were 
neither bound nor ingested  by PMN (AI <  1, PI <  1). 
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Figure 2. Quantitation of the size of CR3 clusters during treatment 
of PMN with PMA.  PMN were treated and labeled as in Fig.  1. 
Quantitation  of gold particles  per cluster  was performed  as de- 
scribed in Materials and Methods. Cells were exposed to PMA for 
(a) 0 min (no PMA), (b) 10 min, (c) 25 min, and (d) 50 min. To 
compare the time course of receptor clustering with that of receptor 
activity, parallel cultures were prepared  in Terasaki tissue culture 
wells. After the 50-rain incubation period described above, C3bi- 
coated erythrocytes were added to all wells and incubation was con- 
tinued for an additional 15 min. The attachment of the red cells to 
PMN was then scored as described in Materials and Methods (solid 
circles in e). Since binding of erythroeytes to PMN requires at least 
15 rain, rapid changes in receptor activity cannot be measured, and 
the amount of binding depicted at each time point represents bind- 
ing events that occurred  during the previous  15-min period.  The 
percent of particles in clusters less than three was derived from the 
data in a-d (open circles in e). 
Results 
Distribution of CR3 on the Surface of  Resting 
and Stimulated PMN 
To observe the distribution of CR3,  PMN were exposed to 
30 ng/ml PMA for varying lengths of time, fixed and labeled 
as whole mounts with the monoclonal antibody OKM10 and 
streptavidin-colloidal  gold  as  described  in  Materials  and 
Methods.  On resting cells CR3 was randomly distributed, 
with many of the gold particles present as individuals (Fig. 
1 a).  After stimulation of the cells for  10 min with PMA, 
CR3 appeared more aggregated (Fig.  1 b), and by 25 min 
large clusters of gold particles were apparent (Fig.  1 c). By 
this time receptors exhibit maximum capacity to bind ligand 
and promote phagocytosis (Wright and Meyer,  1986).  After 
50 min in PMA, the capacity of CR3 to bind ligand and sig- 
nal  phagocytosis  declines  to  baseline  levels  (Wright  and 
Meyer, 1986). At this time the gold particles were again pres- 
ent as individuals, indicating CR3 had disaggregated (Fig.  1 
d). These results were confirmed in separate labeling experi- 
ments using OKM1, an antibody against a different epitope 
on CR3 (data not shown). 
Quantitation of the gold particles per cluster for each time 
Table L Density of CR3 on the Surface of  PMN during 
Treatment with PMA 
Time in PMA  Density of label 
nun  particles~pro 2 
0  (no PMA)  16.3  +  17.6 
10  32.2  +  18.6 
25  37.9  -I- 21.7 
50  21.8  -t-  13.8 
PMN were treated with PMA and labeled with OKM10 as described in Fig. 
1.  Density of label was determined as described in Materials and Methods. 
point confirmed the impression obtained from the electron 
micrographs. On resting cells 60 % of the gold particles were 
present as individuals, and clusters of more than six gold par- 
ticles were barely detectable (Fig. 2 a). Individual gold parti- 
cles declined to 35 % by 10 min in PMA, with a correspond- 
ing increase in the number of gold particles in clusters of 
three or more (Fig. 2 b). By 25 min in PMA there was a fur- 
ther decline in individual particles to 20 %, while the percent 
of particles in clusters of six or more increased to 30 % (Fig. 
2 c). This trend was reversed at 50 min when 50% of the par- 
ticles were once again present as individuals (Fig. 2 d). The 
time course of aggregation of CR3 correlated well with the 
increase in binding activity of this receptor, while disaggre- 
gation correlated with the loss of activity at longer incuba- 
tions (Fig.  2  e). 
The density of gold labeling was measured on samples of 
PMN treated with PMA and labeled with OKM10 (Table I). 
After 10 min in PMA there was a twofold increase in the den- 
sity of label on the cell surface. Receptor density remained 
unchanged at 25  min,  and declined  slightly after 50 min. 
Since these changes in receptor density were relatively small 
and were not temporally correlated with aggregation of CR3, 
it is unlikely that receptor aggregation was an artifact caused 
by changes in receptor density (see Discussion). 
Phorbol  dibutyrate  (PDB)  is  a  hydrophilic  analogue  of 
PMA that has  similar transient effects on the binding  and 
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Figure 3. Quantitation of the size of CR3 clusters during treatment 
of PMN with PDB and after removal of the phorbol ester. PMN 
were incubated for a total of 50 min at 37~  with 300 ng/ml PDB 
added as follows: (a) no PDB, (b) PDB added for the last 25 rain, 
(c) PDB added for 20 rain, washed, PDB readded for another 30 
rain, (d) PDB added for 20 rain, washed, buffer (HAP) added for 
the last 30 min. To effect complete removal of the PDB at the wash 
step described in c and d, cells were incubated for 15 min at 20~ 
in  the  presence  of a  large  excess  of protein-containing  buffer 
(HAP).  Samples were labeled as whole mounts with OKM1 and 
streptavidin gold, and quantitation of gold particles per cluster was 
performed as described  in Materials and Methods. 
The Journal of Cell Biology, Volume 105,  1987  1140 Figure 4. CR3 is not associated with coated pits. PMN were plated 
and incubated for 45 rain at 37~  before labeling with OKM10 and 
preparation  for thin  sectioning  as  described  in  Materials  and 
Methods. a-c show representative coated pits (arrowheads)  from 
resting cells. Bar, 0.2 ~tm. 
phagocytosis-promoting activities of CR3. The loss of recep- 
tor activity observed between 20 and 50 min of incubation 
requires the continuous presence of phorbol ester, because 
if the PDB is washed away from the cells after 20 min, the 
capacity of receptors to bind ligand remains at high levels 
(Wright and Meyer,  1986).  To determine if the disaggrega- 
tion of receptors between 25 to 50 min could be prevented 
by removing the phorbol ester, we incubated PMN for 20 
min with 300 ng/ml PDB, then replaced the phorbol ester 
with buffer and  incubated the cells  for a  further 30 min. 
Whole-mount samples were labeled with OKM1 and strep- 
tavidin  gold as  described  in  Materials  and  Methods.  On 
PMN that were not exposed to PDB, CR3 was randomly dis- 
tributed (Fig. 3 a). After stimulation with PDB for 25 min, 
gold particles marking the location of CR3 were clustered 
(Fig. 3 b), but stimulation of cells with PDB for the full 50 
min caused subsequent disaggregation (Fig. 3 c). On sam- 
ples  from which the PDB was  removed after 20 min and 
replaced with buffer for the succeeding 30-min incubation, 
CR3 remained clustered (Fig.  3 d), again demonstrating a 
correlation between the state of aggregation and the activity 
of the receptor. 
CR3 Is Not Associated with Coated Pits 
To determine if CR3 was present over coated pits in resting 
cells and  whether the aggregates of CR3  observed in  re- 
sponse to PMA were forming over coated pits, we labeled 
CR3 on the surfaces of PMN and prepared thin sections of 
the labeled cells. Label was observed randomly distributed 
over the apical surface of the cell but was not found within 
coated pits on resting cells (Fig. 4). Out of 34 coated pits ob- 
served on resting cells, none contained label for CR3. CR3 
also did not cluster over coated pits during treatment with 
PMA: Only 1 out of 26 coated pits observed contained label 
after either 10 min or 25 min in 30 ng/ml PMA. 
Distribution of Other Surface Antigens on PMN 
To determine whether the aggregation of CR3 in response to 
phorbol  esters  was  specific for that  antigen  or a  general 
phenomenon of PMN surface proteins, we observed the dis- 
tribution of HLA-A,B,C  (MHC  Class  I)  and  Fc  receptor 
(FcRyjo) on PMN  surfaces during incubations with PMA. 
The expression of HLA on the  surfaces of PMN did not 
change in response to treatment with PMA (data not shown). 
Whole mount samples labeled with W6/32 showed HLA to 
be  present  in  a  disaggregated  state,  homogeneously dis- 
tributed over the cell surface at all times of incubation with 
PMA (Fig.  5). 
FcRr~o on resting  PMN  constitutively promotes binding 
and phagocytosis of IgG-coated particles, but the activity of 
FcRr~o declines in the presence of PMA (Wright and Meyer, 
1986).  Labeling of FcRy~o on resting cells was very dense, 
and, in contrast with HLA, the receptor exhibited a clustered 
distribution (Fig. 6 a). The amount of FcRyjo on the surface 
of PMN decreases several-fold during treatment with PMA 
(Wright and Meyer, 1986), and we observed a decline in the 
density  of labeling  with  increasing  time of incubation in 
PMA that was consistent with this observation (Fig. 6 b). Es- 
sentially no label above background was detectable on cells 
after 50 rain in PMA.  Small clusters of gold particles re- 
mained present as long as labeling could be observed, sug- 
gesting that FcRr~o may be present in a constitutive state of 
aggregation. 
Distribution of CR3 on PMN Treated with FMLP 
The chemotactic peptide FMLP causes an increase in the ex- 
pression of CR3 on the surface of PMN (Berger et al., 1984; 
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Figure 5. Distribution of HLA-A,B,C molecules on the surface of 
PMN. PMN were incubated at 37~  for a total of 50 min with 30 
ng/ml PMA added at intervals during the incubation. Samples were 
labeled as whole mounts with W6/32 and streptavidin gold as de- 
scribed in Materials and Methods. Cells were exposed to PMA for 
(a) 0 min (no PMA), (b)  10 min,  (c) 25 rain, and (d) 50 min. 
Detmers et al.  Complement Receptors on Human Neutrophils  1141 Figure 6. Immunolocalization of FcRylo. PMN were incubated at 3"/~  for 50 min. The final 25 min of the incubation were done in the 
absence (a) or the presence (b) of 30 ng/ml PMA. Samples were labeled as whole mounts with 3G8 and streptavidin gold as described 
in Materials and Methods. Bar, 0.2 pm. 
O'Shea et al., 1985). We have observed, however, that stimu- 
lation with FMLP did not enhance the capacity of PMN to 
bind or ingest EC3bi (Table II), although phagocytosis of 
EIgG was enhanced about twofold. Thus, FMLP alters the 
number of CR3 on the cell surface without enhancing its ac- 
tivity.  To observe  whether  FMLP  caused  aggregation  of 
CR3,  PMN were treated with  10  -7 M  FMLP for 10 or 20 
min before labeling with OKMI0 and streptavidin gold. Cells 
treated with FMLP exhibited a twofold increase in the den- 
sity of label present on the cell surface (compare Fig. 7, a 
and b, and Table III). However, FMLP did not cause aggre- 
gation of CR3 (Fig. 7 and 8). Thus aggregation is not a con- 
sequence of receptor externalization, but appears tightly cor- 
related with enhanced receptor activity. 
FMLP causes  PMN  to polarize,  and  the  receptors for 
FMLP have been observed to be preferentially distributed on 
the forward half of polarized cells (Sullivan et al., 1984). We 
observed strong polarization of cells in response to FMLP, 
but CR3 appeared to remain evenly distributed (Fig. 7, b and 
c).  In  blind  comparisons,  no difference in  the pattern of 
labeling could be observed over different parts of the cell. 
The same results were obtained with 5  x  10  -7 M  FMLP 
(data  not  shown).  Counts  of the density of labeling  over 
different areas of polarized cells revealed a  slightly higher 
density of CR3 in the uropod region (Table III). 
Table II. Attachment and Phagocytosis of  Ligand-coated 
Erythrocytes  by PAIN Treated with FMLP or PMA 
Attachment index  Phagocytic index 
Stimulus  EC3bi  EC3bi  EIgG 
-  127  9  185 
FMLP  115  22  376 
PMA  485  229  161 
PMN were allowed to spread for 30 min at 37"C.  The indicated ligand-coated 
erythrocytes  were then  added  simultaneously  with FMLP (5  ￿  10  -7 M) or 
PMA (30 ng/ml), and, afar 45 rain at 37"C,  the attachment and phagocytosis 
of erythroeytes was measured as described in Materials and Methods.  Results 
shown are representative  of three  separate experiments. 
Discussion 
We have investigated the mechanism by which the binding 
capacity of CR3 is regulated. Our observations indicate that 
the capacity of CR3 to efficiently bind ligand is tightly cor- 
related with the state of aggregation of the receptor in the 
plane of the membrane.  Resting cells have randomly dis- 
tributed receptors and very low capacity to bind C3bi-coated 
particles. Upon stimulation of the cells with PMA, the ca- 
pacity to bind C3bi rises with a time course coincident with 
aggregation of the receptor. Upon further incubation with 
phorbol ester, the binding activity of CR3 declines with a 
time course coincident with disaggregation of receptors. 
Stimulation of PMN with PMA causes an increase in the 
expression of CR3 on the cell surface, presumably due to the 
release of specific granules, which appear to comprise an in- 
tracellular store of CR3  (Todd et al.,  1984;  O'Shea et al., 
1985). We do not know the state of  aggregation of CR3 within 
the specific granules before externalization, and the possibil- 
ity exists that receptors are deployed in a pre-aggregated state 
in  response to PMA.  Our  observations suggest,  however, 
that this is most likely not the case: After 10 mln in PMA, 
both the total amount of cell surface CR3 (Wright and Meyer, 
1986) and the density of CR3 (Table I) have increased, but 
additional time was required before maximal aggregation of 
CR3 was observed (Fig. 2). This suggests that the receptors 
Table IlL Density of CR3 on the Surface of  PMN 
during Treatment with FMLP 
Treatment  Area of cell  Density of label 
particles/#m 2 
No FMLP  Periphery  17.5  +  11.0 
10  rain FMLP  Leading edge  33.3  5:21.0 
Uropod  46.3  5-  28,0 
Other areas of periphery  34.3  5:25.0 
PMN were treated with FMLP and labeled with OKM10 as described in Fig. 
7.  Density of label was determined  as described  in Materials  and Methods. 
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l~gure 8. Quantitation of the size of CR3 clusters during treatment 
of PMN with FMLE PMN were treated and labeled as in Fig. 7. 
Quantitation of gold particles per cluster was performed  as de- 
scribed in Materials and Methods. Cells were exposed to FMLP for 
(a) 0 min (no FMLP), (b) 10 rain, or (c) 20 min. 
Figure 7. Immunolocalization of CR3 on cells treated with FMLP. 
PMN were incubated at 370C for a total of  50 min. The final 10 min 
of the incubation were done in the absence (a) or presence (b and 
c) of 10  -7 M FMLP. Samples were labeled as whole mounts with 
OKM10 and  streptavidin  gold  as  described  in  Materials  and 
are deployed in a  non-aggregated state,  and that they then 
form clusters once they are on the cell surface. The aggrega- 
tion of CR3 is also not an automatic consequence of exter- 
nalization of receptors or of changes  in  receptor density, 
since stimulation of cells with FMLP caused externalization 
of intracellular receptors and raised receptor density (Table 
III) but did not lead to aggregation (Fig.  8) or enhanced 
receptor activity (Table 11). 
The mechanism underlying aggregation is not clear, but 
several possibilities can be ruled out. Aggregation is not a 
consequence of interaction with extracellular ligand,  since 
aggregation  was  observed  before the  addition  of ligand. 
Aggregation is probably not a general property of cell mem- 
brane proteins of PMN, since a control transmembrane pro- 
tein, HLA, does not redistribute under the conditions that 
lead to aggregation of CR3. Since the gathering of receptors 
into a nonrandom configuration is likely to be a thermody- 
namically unfavorable reaction, we presume that aggregation 
is an energy-dependent process. PMA is known to activate 
protein kinase C (Castagna et al., 1982; Niedel et al., 1983), 
and we speculate that a phosphorylation event is involved in 
controlling the aggregation of CR3. 
Receptors for low density lipoprotein are preclustered into 
coated pits in the absence of ligand (Anderson et al.,  1976, 
1977), and epidermal growth factor receptors aggregate over 
coated pits after binding of ligand (Haigler et al.,  1979), but 
aggregation of CR3 does not appear to involve clathrin. The 
clustering of CR3 did not occur over coated pits, and CR3 
on resting PMN was not present in coated pits. Alternative 
intracellular proteins that may interact with CR3 are the ele- 
ments of the actin-based cytoskeleton. CR3  is structurally 
homologous with  the  fibronectin receptor (Wright et al., 
1987; Law et al.,  1987; Kishimoto et al.,  1987), a molecule 
known to interact with the actin-based cytoskeleton when ag- 
gregated in 'tadhesion plaques" (Hynes and Destree, 1978; Ali 
and Hynes, 1977). The possibility that CR3 is similarly as- 
sociated with  the  cytoskeleton is  currently under  investi- 
gation. 
How might aggregation of CR3 control its interaction with 
extracellular ligand?  The interaction of CR3  with  mono- 
Methods. Areas trom either the leading edge (b) or uropod region 
(c) of a well-polarized cell are shown. Bar, 0.2 pm. 
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C3bi is not bound by CR3 and must be attached to a surface 
to be recognized by the receptor. Moreover, the distribution 
of C3bi on a surface contributes to the efficiency of recogni- 
tion; particles coated with C3bi in a random distribution are 
bound poorly by phagocytes but particles on which the C3bi 
is clustered are very efficiently bound (Hermanowski-Vosat- 
ka, A., P. A. Detmers, O. Goetze, S. C. Silverstein and S.  D. 
Wright, manuscript in preparation).  Therefore the simplest 
explanation for the role of clustering of receptors and ligand 
is to enhance the avidity of their interaction by lowering the 
apparent off rate. Disassociation of a duster of ligand from 
a cluster of receptors will only occur after simultaneous dis- 
association of all the individual  receptor-ligand  pairs.  Ex- 
perimental  measurements  of the disassociation of monova- 
lent and divalent antibodies from cells indicate that divalent 
antibodies disassociate  at least  10-fold more  slowly than 
monovalent ones (Perelson and DeLisi,  1980;  Mason and 
Williams, 1980). Associations between surface-bound ligand 
and clusters of more than six receptors,  such as we have ob- 
served, should therefore exhibit enormously enhanced  sta- 
bility.  This interpretation does not exclude the possibility 
that conformational changes that influence binding could ac- 
company aggregation  of CR3. 
The labeling  patterns for FcR~lo and CR3 were markedly 
different on both resting and stimulated PMN, thus indicat- 
ing that anti-CR3 was not binding via its Fc domain. Resting 
PMN are capable of binding and phagocytosing  EIgG very 
efficiently  (Wright and Meyer,  1986),  and we observed that 
FcRy~o was  present  in  a  clustered  configuration  on  such 
cells.  Like CR3,  FcRr~o binds monomeric ligand  with low 
affinity, and only aggregates oflgG are effectively recognized 
by PMN (Kurlander and Batker,  1982).  This difference  in 
affinity is potentially explained by the clustered distribution 
of FCRr~o, and this may represent another example in which 
the aggregation  state of ligand  and receptor  controls  their 
interactions. 
Since it is likely that PMA acts on an intraeellular target, 
protein  kinase  C,  our results  suggest that aggregation  of 
receptors  may  be  a  mechanism  by  which  intracellular 
changes are communicated to the cell surface. The reciprocal 
may also occur: Aggregation of  other receptors after addition 
of ligand or anti-receptor  antibodies may create high affinity 
sites on the cytoplasmic side of the plasma membrane for the 
binding of regulatory proteins.  These studies may therefore 
provide a model for understanding how ligation of receptors 
at the cell  surface  and the consequent aggregation  of the 
receptors  may signal  intraceUular events. 
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